These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 4660406

  • 1. [Instrumental coagulography].
    Rybakov VK, Gurkova EN.
    Ter Arkh; 1972 Sep; 44(9):63-7. PubMed ID: 4660406
    [No Abstract] [Full Text] [Related]

  • 2. [Action of atmospheric factors on coagulation and fibrinolysis processes].
    Magyarósi G, Zsigmondovits E, Koós T.
    Med Interna (Bucur); 1974 Feb; 26(2):237-44. PubMed ID: 4828939
    [No Abstract] [Full Text] [Related]

  • 3. [Changes of certain indicators of blood coagulation in patients with coronary arteriosclerosis and hypertensive disease].
    Pliutto AM.
    Lab Delo; 1974 Feb; 8(0):465-8. PubMed ID: 4139365
    [No Abstract] [Full Text] [Related]

  • 4. [Blood coagulation and fibrinolysis in ischemic heart disease. The relationship to risk factors].
    Andreenko GV, Belokon' NA, Zabotina ON, Karabasova MA.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1988 Feb; (1):5-19. PubMed ID: 3282549
    [Abstract] [Full Text] [Related]

  • 5. [Functional state of the coagulation and fibrinolytic systems of blood in patients with coronary arteriosclerosis].
    Shchigel'skiĭ VI.
    Vrach Delo; 1974 Feb; 4():75-8. PubMed ID: 4831872
    [No Abstract] [Full Text] [Related]

  • 6. [Blood coagulation and fibrinolysis in patients with arterioslcerotic cardiosclerosis complicated by chronic circulatory insufficiency].
    Mamedov MB.
    Vrach Delo; 1975 Nov; (11):12-5. PubMed ID: 1199036
    [No Abstract] [Full Text] [Related]

  • 7. [Coagulation, fibrinolysis and various diseases: coronary disease].
    Yamazaki H, Sano T.
    Nihon Rinsho; 1974 May 10; 32(5):1066-9. PubMed ID: 4858913
    [No Abstract] [Full Text] [Related]

  • 8. [Takata-Ara and Weltmann's reactions in patients over 50 with hypertensive disease and coronary arteriosclerosis].
    Fesenko IP.
    Vrach Delo; 1973 Jun 10; 6():33-5. PubMed ID: 4755126
    [No Abstract] [Full Text] [Related]

  • 9. [Significance of the test using local hypoxia in the evaluation of the reactive capacity of coagulation and anticoagulation systems of blood in patients with arteriosclerotic cardiosclerosis].
    Shpirt EIa.
    Kardiologiia; 1973 Dec 10; 13(12):105-6. PubMed ID: 4778813
    [No Abstract] [Full Text] [Related]

  • 10. [Diagnostic importance of the atherothrombophilia index in cardiologic diseases].
    Zolotarev AE, Zakatova LV.
    Vrach Delo; 1980 Jul 10; (7):29-30. PubMed ID: 7415086
    [No Abstract] [Full Text] [Related]

  • 11. Serum fibrinolytic activity and recalcified plasma clotting time in ischaemic heart disease.
    Arora A, Gupta JC, Arora MM.
    J Indian Med Assoc; 1969 Nov 16; 53(10):477-82. PubMed ID: 5368384
    [No Abstract] [Full Text] [Related]

  • 12. [Fibrinolysis incidence in arteriosclerosis-induced illnesses as well as in arteriosclerosis positive and negative syntropic diseases].
    Schulz FH, Bach G, Künzel A.
    Dtsch Gesundheitsw; 1970 Apr 16; 25(15):682-4. PubMed ID: 5483709
    [No Abstract] [Full Text] [Related]

  • 13. [Diagnosis of thrombophilia in atherosclerosis patients].
    Reimann H, Norden C, Heine H, Ermolin G, Ignaschenkowa G.
    Z Med Lab Diagn; 1989 Apr 16; 30(1):45-7. PubMed ID: 2718578
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of submaximal physical exertion on serum lipid levels and the blood coagulation and fibrinolysis systems in patients with arteriosclerosis].
    Markiewicz K, Cholewa M, Jazdzewski B, Gawor Z.
    Pol Tyg Lek; 1989 Apr 16; 39(25-26):857-61. PubMed ID: 6494044
    [No Abstract] [Full Text] [Related]

  • 15. [Studies of thrombophilic syndromes. II. Preliminary research on the behavior of the plasmatic inhibitor of the product of the contact reaction in coronary, cerebral and peripheral arteriosclerosis].
    Neri Serneri GG, Paoletti P, Silvestrini E, Masotti G.
    Riv Crit Clin Med; 1968 Apr 16; 68(4):289-323. PubMed ID: 5746286
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of exogenous heparin on heparinemia and coagulation in coronary arteriosclerosis].
    Szigeti I, Kótay-Lákatos E, Vertán MZ, Kiss R.
    Med Interna (Bucur); 1967 May 16; 19(5):549-52. PubMed ID: 6077944
    [No Abstract] [Full Text] [Related]

  • 17. [Seasonal changes in the fibrinolytic system of the blood in patients with coronary arteriosclerosis].
    Semenko IF.
    Klin Med (Mosk); 1973 Aug 16; 51(8):57-63. PubMed ID: 4754475
    [No Abstract] [Full Text] [Related]

  • 18. Soluble thrombomodulin as predictor of incident coronary heart disease.
    Salomaa V, Wu KK.
    Lancet; 1999 Nov 06; 354(9190):1646-7. PubMed ID: 10560702
    [No Abstract] [Full Text] [Related]

  • 19. [Studies on coagulation and fibrinolysis. I. Fibrinolysodynamicogram and its application (author's transl)].
    Wang KQ, Shi QH, Lu ZQ, Cheng XK.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Jun 06; 2(2):93-7. PubMed ID: 6448715
    [No Abstract] [Full Text] [Related]

  • 20. [Role of erythrocytes in blood coagulation and fibrinolysis in patients with atherosclerosis of the coronary arteries].
    Ermolaev VV.
    Klin Med (Mosk); 1977 Oct 06; 55(10):82-90. PubMed ID: 592699
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.